Xalatana Eye Drops
PDF Leaflet Revision Date: 18 May 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of elevated intraocular pressure in glaucoma and ocular hypertension.
Dosage (summary)
One drop in the affected eye(s) once daily, preferably in the evening.
Onset of Action / Duration
Onset: 3-4 hours, Duration: 24 hours
Special Populations
- Paediatric patients
- Elderly patients
- Patients with asthma
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not established in breastfeeding.
Key Drug Interactions
- Additive effect with beta-blockers
- Avoid concurrent use of multiple prostaglandins
Contraindications
- Hypersensitivity to latanoprost or benzalkonium chloride
- Pregnancy
- Lactation
Common side effects
- Iris hyperpigmentation
- Eye irritation
- Eyelash changes
- Macular oedema
Counselling Points
- Remove contact lenses before use
- Monitor for eye color changes
- Do not drive if vision is blurred after use
Serious warnings
- May cause increased iris pigmentation
- Caution in patients with macular oedema risk
- Risk of herpetic keratitis
Important Disclaimer
The Xalatana Eye Drops professional information leaflet below is the property of Upjohn South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
